Clinical trial reports

  • Oncology Phase III Endpoint Architecture, 2024–2026
  • Does PFS Displace OS as the Primary Endpoint in Phase III Lymphoma Trials?
  • OS vs PFS as Primary Endpoints in Phase III Colorectal Cancer Trials
  • When Do Kidney Cancer Phase III Trials Use OS Instead of PFS?
  • Where Do OS and PFS Sit in Phase III Pancreatic Cancer Trials?
  • How Are OS, PFS, and Combined OS+PFS Used Across European Phase III Oncology Trials?
  • Is Overall Survival Still the Primary Endpoint Anchor Across European Phase III Oncology Trials?
  • Is Overall Survival Still the Primary Endpoint Anchor in European Phase III Gastric Cancer Trials?
  • Are Digital Recruitment Channels Still Underused in European Phase III Gastric and Esophageal Cancer Trials?
  • From PFS to Recurrence-Free Survival: How Phase III Breast Cancer Trials Structure Endpoints in Europe
  • Is Overall Survival Still the Endpoint Anchor in European Phase III Lung Cancer Trials?
  • Digital Recruitment Channels Still Underused in European Phase III Breast Cancer Trials